Cargando…
Association of ARMS2 genotype with response to anti-vascular endothelial growth factor treatment in polypoidal choroidal vasculopathy
BACKGROUND: To investigate whether genetic risk variants for age-related macular degeneration (AMD) are associated with response to intravitreal anti-vascular endothelial growth factor (VEGF) in polypoidal choroidal vasculopathy (PCV) patients. METHODS: This prospective cohort study included 95 trea...
Autores principales: | Park, Un Chul, Shin, Joo Young, Chung, Hum, Yu, Hyeong Gon |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5719580/ https://www.ncbi.nlm.nih.gov/pubmed/29212537 http://dx.doi.org/10.1186/s12886-017-0631-z |
Ejemplares similares
-
Anti-vascular endothelial growth factor drugs in polypoidal choroidal vasculopathy
por: Chhablani, Jay Kumar
Publicado: (2011) -
Intravitreal Anti-vascular Endothelial Growth Factor for Newly Diagnosed Symptomatic Polypoidal Choroidal Vasculopathy with Extrafoveal Polyps
por: Kim, Jae Hui, et al.
Publicado: (2015) -
Intravitreal Anti-vascular Endothelial Growth Factor for Treating Polypoidal Choroidal Vasculopathy with Grape-like Polyp Clusters
por: Chang, Young Suk, et al.
Publicado: (2016) -
Peripapillary Choroidal Thickness Change of Polypoidal Choroidal Vasculopathy after Anti-vascular Endothelial Growth Factor
por: Lee, Kyou Ho, et al.
Publicado: (2017) -
Dynamic changes in choroidal conditions during anti-vascular endothelial growth factor therapy in polypoidal choroidal vasculopathy
por: Nagai, Norihiro, et al.
Publicado: (2019)